InSphero and Darwin Microfluidics signed distribution agreement to facilitate purchasing InSphero’s 3D in vitro products within the European Union
Zurich, Switzerland – September 7, 2023
InSphero today announced that the company is making their 3D in vitro products available to researchers in the European Union market more easily by signing a distribution agreement with Darwin Microfluidics, an innovative startup dedicated to bringing advanced microfluidic solutions to researchers worldwide.
InSphero, a global pioneer in 3D cell culture and organ-on-chip technology, is well known for its 3D in vitro products, from Akura™ Plate Technology to Akura™ MPS systems. Simplified aggregation and handling of spheroids in SBS standard Akura™ Plates facilitates transfer and integration of 3D models in micro-physiological systems by automated liquid-handling systems.
“I am looking forward to working with the scientists of Darwin Microfluidics to expand our range of applications for researchers in the microfluidics field, said Paul Clémençon, Head of Business Development of InSphero.” Combining our scalable, reliable, and automation-compatible Akura™ Plate Formats with microfluidic applications helps scientists to address current challenges in drug development.
With a passion for microfluidics, Darwin Microfluidics aims to enable research laboratories and members of the scientific community to access the best available instruments and accessories in the market.
“Darwin Microfluidics offers a deep expertise in biotechnology, microfluidics, lab-on-a-chip and organ-on-chip technology. We are experienced in business development of innovative products, and we are thrilled to offer InSphero’s Akura™ Plate and OoC Technology to our scientific community,” said Vincent Rocher, CEO of Darwin Microfluidics.
# # # #
About Darwin Microfluidics
Darwin Microfluidics is a young innovative startup founded in October 2017. This team of engineers and PhDs firmly believe microfluidics to be the key to a new technological revolution. Their aim is simple but huge: enable worldwide research laboratories and members of the scientific community to access the most innovative instruments and accessories for microfluidics. Scientists can rely on the multidisciplinary scientific expertise and attentive customer support of Darwin Microfluidics team.
About InSphero
InSphero is the only 3D in vitro model company with the platform and expertise to modernize drug discovery in a way that empowers researchers to reach their full potential. Our innovative spheroid-based models allow more effective, safe therapies to contact the clinic through superior robustness, reliability, reproducibility, and scalability. InSphero’s goal is to inspire the next generation of breakthrough therapies through customer obsession, commitment to innovation, and the model of excellence.
Learn more at insphero.com. Follow the company on LinkedIn and sign up for the Scientific Newsletter.
Media Contacts
InSphero
Paul Clémençon
+41 44 5150490
paul.clemencon@insphero.com
Darwin Microfluidics
Vincent Rocher
+33 189 197 051
vincent.rocher@darwin-microfluidics.com
